Abstract
G on treatment of allergic rhinitis and strategies to manage anaphylaxis were among several key practice parameters released in 2015. In addition, a few key papers commented on the cross-reactivity and tolerability of cephalosporins in patients who have experienced hypersensitivity reactions to these agents in the past, and on the use of live attenuated in uenza vaccine (LAIV) in those with an egg allergy. These key papers are reviewed here; for additional information, clinicians are encouraged to access the full citations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have